Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022, 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial.
Elite Pharmaceuticals, Inc Appoints Robert Chen as Chief Financial Officer phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
(1)
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ( Elite or the Company ) (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ( Prasco ), has launched Elite s generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ( Agreement ) with Prasco for Elite s Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ( Loxapine Capsules ). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical s label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will manufacture the product.
Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules
ACCESSWIRE
05 May 2021, 00:31 GMT+10
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ( Elite or the Company ) (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ( Prasco ), has launched Elite s generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ( Agreement ) with Prasco for Elite s Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ( Loxapine Capsules ). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical s label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will m
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ( Elite or the Company ) (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CFO), effective May 17, 2021. Mr. Bregman and will report to Elite s President and CEO, Nasrat Hakim.
Mr. Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering & Environmental Services and Controller at Chemtrade Logistics. He held corporate financial positions at Chemetall and National Starch & Chemical Company and was a supervisor and senior auditor at Ernst & Young. Mr. Bregman brings experience in financial accounting, financial planning & analysis, governance & compliance, financial auditing, Sarbanes-Oxley Act (SOX) compliance, and cost accountin